Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Ani Pharmaceuticals Inc's Business Segments
Ani Pharmaceuticals Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q2 FY2026
Reportable Segments
2
Largest Segment
Rare Disease and Brands
Total Revenue
$ 266
Regions Reported
-
Revenue Share by Reportable Segment - Q2 FY2026
- Rare Disease and Brands62.2%
- Generics and Other37.8%
Revenue by Reportable Segment - Q2 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Rare Disease and Brands | $ 165 | 62.2% |
| Generics and Other | $ 101 | 37.8% |
Revenue by Product & Service Category - Q2 FY2026
- Total Sales of Rare Disease and Brands62.2%
- Total sales of rare disease pharmaceutical products51.1%
- Sales of Cortrophin Gel44%
- Total Sales of Generics and Other37.8%
- Sales of generic pharmaceutical products37.2%
- Sales of ILUVIEN and YUTIQ7%
- Sales of Established Brand Royalties and Other Revenues6.7%
- Sales of Established Brands4.4%
- Unapproved Products2.1%
- Sales of Generic Other Revenues0.6%
Revenue by Product & Service Category - Q2 FY2026
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Total Sales of Rare Disease and Brands | $ 165 | 62.2% |
| Total sales of rare disease pharmaceutical products | $ 136 | 51.1% |
| Sales of Cortrophin Gel | $ 117 | 44% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
7 more categories available
Sign in to unlock the full Ani Pharmaceuticals Inc dataset.
Description of Ani Pharmaceuticals Inc
Ani Pharmaceuticals Inc. is an innovative specialty pharmaceutical company that focuses on the development, manufacturing, and commercialization of high-quality generic and branded prescription pharmaceuticals. The company was founded in 2002 and is headquartered in Baudette, Minnesota, United States.
Ani Pharmaceuticals operates in four main segments: Generic Pharmaceuticals, Branded Pharmaceuticals, Contract Manufacturing, and Specialty Pharmaceuticals. The Generic Pharmaceuticals segment develops and markets generic products that are equivalent to their brand-name equivalents but are lower-priced alternatives. The Branded Pharmaceuticals segment focuses on branded products that are marketed to specific niche markets, usually where there are no generic alternatives. The Contract Manufacturing segment provides contract manufacturing services to other pharmaceutical companies, utilizing the company's expertise in formulation development, analytical testing, and commercial-scale manufacturing. The Specialty Pharmaceuticals segment develops and markets specialty products that typically have lower competition, smaller markets, and higher margins than generic or branded products.
Ani Pharmaceuticals has a portfolio of over 100 generic and branded products covering several therapeutic categories, including oncology, cardiology, dermatology, pain management, and more. It markets its products through wholesalers, distributors, retailers, and other customers in the United States, Canada, and other international markets.
Apart from its product portfolio, Ani Pharmaceuticals has a state-of-the-art FDA-approved manufacturing facility that can produce several dosage forms such as tablets, capsules, creams, gels, and liquids. The company has a highly experienced team of scientists, researchers, and technicians who work relentlessly to develop new and innovative products that meet the evolving needs of the healthcare industry.
Ani Pharmaceuticals is committed to achieving high levels of growth through organic growth and strategic partnerships and acquisitions. The company has made several strategic acquisitions over the years to expand its product pipeline and enhance its manufacturing capabilities. It also partners with other pharmaceutical companies to develop and commercialize joint products.
In summary, Ani Pharmaceuticals Inc. is a leading specialty pharmaceutical company with a strong focus on the development, manufacturing, and commercialization of high-quality generic and branded prescription pharmaceuticals. The company has a diversified product portfolio, state-of-the-art manufacturing facility, and a highly experienced team of experts. It is committed to innovation, growth, and exceeding the expectations of its customers, employees, and shareholders.
Ani Pharmaceuticals operates in four main segments: Generic Pharmaceuticals, Branded Pharmaceuticals, Contract Manufacturing, and Specialty Pharmaceuticals. The Generic Pharmaceuticals segment develops and markets generic products that are equivalent to their brand-name equivalents but are lower-priced alternatives. The Branded Pharmaceuticals segment focuses on branded products that are marketed to specific niche markets, usually where there are no generic alternatives. The Contract Manufacturing segment provides contract manufacturing services to other pharmaceutical companies, utilizing the company's expertise in formulation development, analytical testing, and commercial-scale manufacturing. The Specialty Pharmaceuticals segment develops and markets specialty products that typically have lower competition, smaller markets, and higher margins than generic or branded products.
Ani Pharmaceuticals has a portfolio of over 100 generic and branded products covering several therapeutic categories, including oncology, cardiology, dermatology, pain management, and more. It markets its products through wholesalers, distributors, retailers, and other customers in the United States, Canada, and other international markets.
Apart from its product portfolio, Ani Pharmaceuticals has a state-of-the-art FDA-approved manufacturing facility that can produce several dosage forms such as tablets, capsules, creams, gels, and liquids. The company has a highly experienced team of scientists, researchers, and technicians who work relentlessly to develop new and innovative products that meet the evolving needs of the healthcare industry.
Ani Pharmaceuticals is committed to achieving high levels of growth through organic growth and strategic partnerships and acquisitions. The company has made several strategic acquisitions over the years to expand its product pipeline and enhance its manufacturing capabilities. It also partners with other pharmaceutical companies to develop and commercialize joint products.
In summary, Ani Pharmaceuticals Inc. is a leading specialty pharmaceutical company with a strong focus on the development, manufacturing, and commercialization of high-quality generic and branded prescription pharmaceuticals. The company has a diversified product portfolio, state-of-the-art manufacturing facility, and a highly experienced team of experts. It is committed to innovation, growth, and exceeding the expectations of its customers, employees, and shareholders.
Comprehensive Overview of Ani Pharmaceuticals Inc: Segments, Products, and Services
Ani Pharmaceuticals Inc. is a notable player in the specialty pharmaceutical sector, offering a diverse array of products and services across multiple therapeutic landscapes, encompassing womens health, oncology, ophthalmology, and veterinary medicine. The company’s dedication to transforming patient care through innovative and premium-quality pharmaceutical solutions is evident in their extensive portfolio.
Segments
1. Branded Pharmaceuticals:
- This segment is dedicated to the research, development, manufacturing, marketing, and distribution of branded medications targeted at specific therapeutic areas.
- Key Products:
- Elestrin: An estrogen topical gel formulated to alleviate menopausal symptoms like hot flashes, night sweats, and vaginal dryness.
- Ovaban: A synthetic progestin used in veterinary medicine, particularly for treating reproductive disorders in female dogs, including false pregnancy and cystic endometrial hyperplasia.
- Luveniq: Specifically developed for Hunter syndrome, a rare genetic disorder; it addresses the deficiency of the enzyme iduronate-2-sulfatase.
- Cortrophin: Utilized in the management of various autoimmune and inflammatory conditions such as multiple sclerosis, lupus, and allergies.
2. Generic Pharmaceuticals:
- This segment focuses on the development, manufacturing, and marketing of generic medications, providing cost-effective alternatives for various therapeutic areas.
- Key Products:
- Hydrocortisone: Used in treating skin conditions, including eczema, psoriasis, and dermatitis, this medication is integral in anti-inflammatory treatments.
- Diclofenac/Misoprostol: Combines an anti-inflammatory with a protective agent, recommended for conditions like rheumatoid arthritis and osteoarthritis.
- Methimazole: Employed in managing hyperthyroidism, helping regulate thyroid hormone production in patients.
3. Contract Manufacturing:
- Ani Pharmaceuticals extends its expertise by offering contract manufacturing services to other pharmaceutical companies, ensuring a streamlined process from drug development to final product packaging.
- Key Services:
- Preformulation: Conducting numerous experimental studies to evaluate the physicochemical properties of drug substances in order to identify optimal candidates for further development.
- Formulation: The creation of a final drug product involves rigorous processes such as granulation, blending, compression, coating, and packaging.
- Clinical Trial Material Manufacturing: Producing small batches of drug products tailored for clinical trials to evaluate their safety and efficacy.
- Scale-Up: This involves transferring lab-scale manufacturing processes to commercial levels, ensuring products can be produced safely and sustainably.
- Commercial Manufacturing: This encompasses the full production cycle of large batches of pharmaceuticals for market distribution, incorporating both upstream and downstream manufacturing processes.
Products
- Elestrin: A convenient topical gel providing effective symptom relief for menopausal women, focusing on improving their quality of life.
- Ovaban: An important veterinary medication that addresses reproductive hormonal issues, effectively supporting the health and wellbeing of female dogs.
- Luveniq: Addresses the needs of patients suffering from Hunter syndrome, targeting the metabolic deficiencies associated with the disorder.
- Cortrophin: A versatile medication utilized in treating a range of health conditions, emphasizing its role in the management of immune and inflammatory diseases.
- Hydrocortisone: Widely recognized for its efficacy in various skin-related conditions, playing a crucial role in dermatological therapy.
- Diclofenac/Misoprostol: This formulation provides both pain relief and gastrointestinal protection, making it valuable in orthopedic and rheumatological treatments.
- Methimazole: Critical in the management of hyperthyroidism, offering a therapeutic option to balance thyroid hormone levels.
Services
- Preformulation Services: A comprehensive suite of studies aimed at characterizing drug substances, facilitating the progression of promising compounds to development stages.
- Formulation Development: An integrated approach that ensures drug products are formulated efficiently and effectively, ready for clinical and commercial phases.
- Clinical Trial Material Manufacturing: Focused on the production of clinical trial materials that adhere to regulatory standards, ensuring the reliability of trial data.
- Scale-Up Services: Careful processes designed to transition from laboratory production to industrial-scale manufacturing, maintaining product integrity and safety.
- Commercial Manufacturing: High-volume production capabilities ensure that pharmaceuticals reach the market efficiently and meet demand, with a robust quality assurance framework.
Conclusion
Ani Pharmaceuticals Inc. stands out as a comprehensive provider of pharmaceutical solutions, underpinned by a commitment to innovation and quality. By combining a diverse portfolio of branded and generic products with extensive contract manufacturing capabilities, Ani Pharmaceuticals continues to play a pivotal role in enhancing healthcare outcomes globally, responding to the evolving needs of patients and healthcare providers across a range of therapeutic areas. Their strategic focus on various segments ensures they remain at the forefront of the pharmaceutical industry.
Ani Pharmaceuticals Inc. is a notable player in the specialty pharmaceutical sector, offering a diverse array of products and services across multiple therapeutic landscapes, encompassing womens health, oncology, ophthalmology, and veterinary medicine. The company’s dedication to transforming patient care through innovative and premium-quality pharmaceutical solutions is evident in their extensive portfolio.
Segments
1. Branded Pharmaceuticals:
- This segment is dedicated to the research, development, manufacturing, marketing, and distribution of branded medications targeted at specific therapeutic areas.
- Key Products:
- Elestrin: An estrogen topical gel formulated to alleviate menopausal symptoms like hot flashes, night sweats, and vaginal dryness.
- Ovaban: A synthetic progestin used in veterinary medicine, particularly for treating reproductive disorders in female dogs, including false pregnancy and cystic endometrial hyperplasia.
- Luveniq: Specifically developed for Hunter syndrome, a rare genetic disorder; it addresses the deficiency of the enzyme iduronate-2-sulfatase.
- Cortrophin: Utilized in the management of various autoimmune and inflammatory conditions such as multiple sclerosis, lupus, and allergies.
2. Generic Pharmaceuticals:
- This segment focuses on the development, manufacturing, and marketing of generic medications, providing cost-effective alternatives for various therapeutic areas.
- Key Products:
- Hydrocortisone: Used in treating skin conditions, including eczema, psoriasis, and dermatitis, this medication is integral in anti-inflammatory treatments.
- Diclofenac/Misoprostol: Combines an anti-inflammatory with a protective agent, recommended for conditions like rheumatoid arthritis and osteoarthritis.
- Methimazole: Employed in managing hyperthyroidism, helping regulate thyroid hormone production in patients.
3. Contract Manufacturing:
- Ani Pharmaceuticals extends its expertise by offering contract manufacturing services to other pharmaceutical companies, ensuring a streamlined process from drug development to final product packaging.
- Key Services:
- Preformulation: Conducting numerous experimental studies to evaluate the physicochemical properties of drug substances in order to identify optimal candidates for further development.
- Formulation: The creation of a final drug product involves rigorous processes such as granulation, blending, compression, coating, and packaging.
- Clinical Trial Material Manufacturing: Producing small batches of drug products tailored for clinical trials to evaluate their safety and efficacy.
- Scale-Up: This involves transferring lab-scale manufacturing processes to commercial levels, ensuring products can be produced safely and sustainably.
- Commercial Manufacturing: This encompasses the full production cycle of large batches of pharmaceuticals for market distribution, incorporating both upstream and downstream manufacturing processes.
Products
- Elestrin: A convenient topical gel providing effective symptom relief for menopausal women, focusing on improving their quality of life.
- Ovaban: An important veterinary medication that addresses reproductive hormonal issues, effectively supporting the health and wellbeing of female dogs.
- Luveniq: Addresses the needs of patients suffering from Hunter syndrome, targeting the metabolic deficiencies associated with the disorder.
- Cortrophin: A versatile medication utilized in treating a range of health conditions, emphasizing its role in the management of immune and inflammatory diseases.
- Hydrocortisone: Widely recognized for its efficacy in various skin-related conditions, playing a crucial role in dermatological therapy.
- Diclofenac/Misoprostol: This formulation provides both pain relief and gastrointestinal protection, making it valuable in orthopedic and rheumatological treatments.
- Methimazole: Critical in the management of hyperthyroidism, offering a therapeutic option to balance thyroid hormone levels.
Services
- Preformulation Services: A comprehensive suite of studies aimed at characterizing drug substances, facilitating the progression of promising compounds to development stages.
- Formulation Development: An integrated approach that ensures drug products are formulated efficiently and effectively, ready for clinical and commercial phases.
- Clinical Trial Material Manufacturing: Focused on the production of clinical trial materials that adhere to regulatory standards, ensuring the reliability of trial data.
- Scale-Up Services: Careful processes designed to transition from laboratory production to industrial-scale manufacturing, maintaining product integrity and safety.
- Commercial Manufacturing: High-volume production capabilities ensure that pharmaceuticals reach the market efficiently and meet demand, with a robust quality assurance framework.
Conclusion
Ani Pharmaceuticals Inc. stands out as a comprehensive provider of pharmaceutical solutions, underpinned by a commitment to innovation and quality. By combining a diverse portfolio of branded and generic products with extensive contract manufacturing capabilities, Ani Pharmaceuticals continues to play a pivotal role in enhancing healthcare outcomes globally, responding to the evolving needs of patients and healthcare providers across a range of therapeutic areas. Their strategic focus on various segments ensures they remain at the forefront of the pharmaceutical industry.